New Medications May Offer Hope to Drinkers Battling Alcohol Dependence

Individuals who experience the physical, mental and social symptoms associated with alcohol dependence are offered hope through the results of two recent studies by researchers at the Medical University of South Carolina (MUSC). In separate investigations, researchers found favorable results for a medication to help heavy drinkers who are trying to modify their consumption, as well as a medication to reduce alcohol withdrawal symptoms and prevent relapse.

In a landmark study, MUSC researchers working with investigators at the University of Virginia Health System and elsewhere have found that topiramate, an effective therapeutic medication, not only decreases heavy drinking, but it also lowers all liver enzymes, plasma cholesterol, body mass index (BMI), and systolic and diastolic blood pressure — all of which tend to increase with heavy drinking and pose such serious health risks as heart disease and cirrhosis. Notably, these combined effects suggest that topiramate may decrease the risk of heart disease in alcohol dependent individuals.

“These findings add growing data indicating that heavy drinkers who modify their drinking with the help of medication and supportive counseling may see an improvement in health and well-being, as well as a potential reduction of risk for the development of heart and liver diseases. This shows that treatment of alcoholism has potential health benefits beyond the immediate behavioral and emotional improvement caused by a reduction in drinking” said Raymond Anton, M.D., distinguished university professor.

By decreasing liver enzymes and cholesterol levels, topiramate also may reduce the risk of fatty liver disease, which leads to cirrhosis – a common consequence to end-stage liver disease leading to death in some alcoholics.

Additionally, topiramate significantly contributed to a decline in obsessive thoughts and compulsions, components of alcohol craving, and also had a greater improvement in their “overall quality of life,” and specifically an improvement in general and leisure activities and household duties, as well as a reduction in sleep disturbances.

The Food and Drug Administration has approved topiramate for seizures and migraine headaches, but it is not currently approved for treating alcohol dependence. Ortho-McNeil Neurologics, Inc., manufactures topiramate and provided study funding.

Results from the nationwide 14-week trial involving 371 male and female diagnosed alcoholics was published in the June 9 issue of the Archives of Internal Medicine.

In addition, Anton presented initial results from a separate investigation of a 14-week double-blind, placebo-controlled study utilizing the PROMETA ® alcoholism treatment program, developed by Hythiam, inc., at the 2008 Research Society on Alcoholism (RSA) conference in Washington D.C.

Anton suggested that alcohol dependence programs are few in number and not exceptionally effective, which is particularly true for individuals who experience alcohol withdrawal symptoms. PROMETA ®, a combination of generic medications, reduced cravings and alcohol withdrawal symptoms, promoted abstinence, and improved mood and sleep only in those who had symptoms of alcohol withdrawal. Although the PROMETA ® Protocol has been marketed nationally, this was the first scientific study examining its utility in individuals with alcohol dependence.

At the time of the RSA presentation, the data presented covered the initial six-week active treatment phase of the 14-week study. While these are initial findings, additional evaluation of the full 14-week study data is ongoing, and Anton plans to release these specifics in a peer-reviewed publication.

MUSC has an ongoing clinical trial program studying new medications for the treatment of alcohol use disorders. For more information call 843-792-2727.
__________
source: Newswise Medical News

More Treatment & Detox Articles

Doctors helping doctors

GUELPH, ONT. NICOLE VISSCHEDYK The Canadian Press “You walked into the office and sat down. Did it ever cross your mind that I wasn’t sober?” Sitting in the quiet, bright office of a doctor, the question jarred me. Dr. Graeme Cunningham is director of the addiction division at the Homewood Health Centre. He answered his….

Challenges You May Encounter in Drug Abuse Treatment

The decision to enter drug abuse treatment is, in essence, a decision to enter into a new way of life. After months or years of drug abuse, the damaging effects of drugs have created a negative quality of life that affects both a person’s physical and psychological well-being. According to the National Institute on Drug….

Signs of drug and alcohol abuse in teenagers

A large number of the total number of world population is under substance abuse. Since, most of the populations under substance abuse are teenagers; it has become the need of the time that parents, must get educated and made aware of the signs and symptoms and also about the adverse effects and treatment options available….

Getting A Degree In Drinking

For many students at Ohio State, drinking is a part of life. For about 44 percent of those students, it’s a large part. That’s the percentage of students who fit the profile of “high-risk drinkers,” according to the National Institute on Alcohol Abuse and Alcoholism. With nearly half of college students characterized as high-risk drinkers,….

Surviving Meth Addiction

Methamphetamine is a dangerous drug that comes with significant risk of addiction which is very difficult to treat. The symptoms of withdrawal can become so severe that many users find themselves back in the habit of using just to avoid the discomfort, sleepless nights and debilitating urges that come with not using. Psychologically, methamphetamine can….